… This grant builds upon the research from a prior grant: Delivery of Cerebral Dopamine … CDNF microbubbles and the drug alone. Importance of This Research for the Development of a New PD Therapy:       … has limited clinical use. Noninvasive drug delivery for early-stage patients throughout the diseased regions may be …

… This grant builds upon the research from a prior grant: Promoting Mitochondrial … mitochondrial movement in those cells. Importance of This Research for the Development of a New PD Therapy: Because … Research Grant …

… (PD) investigators capitalizes on their extensive PD research experience and new understanding of the … will exploit these new insights and harness the researchers’ collective expertise to screen MAbs from one of … PDD with a pharmaceutical company partner. Relevance to Diagnosis/Treatment of Parkinson’s Disease: This project …

… To track the fate of alpha-synuclein in neurons, researchers use imaging tools (‘reporters’) consisting of … test tube and when produced in cultured neurons. Impact on Diagnosis/Treatment of Parkinson’s disease:  The alpha-synuclein reporter developed here will enable researchers to better understand how protein aggregates are …

… recommendations through group consensus. Impact on Diagnosis/Treatment of Parkinson’s disease:  This project could impact how researchers design and conduct clinical trials for cognitive … therapies. Our results will help guide clinicians, researchers and regulatory agencies in industry and the FDA …

… changes over time. The collected data will be shared with researchers worldwide to help develop better treatments and personalized care. Impact on Diagnosis/Treatment of Parkinson’s disease: This … symptoms over time. This data will be shared with approved researchers worldwide, ensuring privacy of the participants …